- Home
- LUCD vs APYX Comparison
LUCD vs APYX Comparison
Compare LUCD & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- APYX
- Stock Information
- Founded
- LUCD 2018
- APYX 1982
- Country
- LUCD United States
- APYX United States
- Employees
- LUCD 70
- APYX N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- APYX Medical/Dental Instruments
- Sector
- LUCD Health Care
- APYX Health Care
- Exchange
- LUCD Nasdaq
- APYX Nasdaq
- Market Cap
- LUCD 108.0M
- APYX 85.0M
- IPO Year
- LUCD 2021
- APYX 1987
- Fundamental
- Price
- LUCD $1.07
- APYX $2.15
- Analyst Decision
- LUCD Strong Buy
- APYX Hold
- Analyst Count
- LUCD 5
- APYX 2
- Target Price
- LUCD $3.65
- APYX N/A
- AVG Volume (30 Days)
- LUCD 1.6M
- APYX 57.2K
- Earning Date
- LUCD 11-12-2025
- APYX 11-07-2025
- Dividend Yield
- LUCD N/A
- APYX N/A
- EPS Growth
- LUCD N/A
- APYX N/A
- EPS
- LUCD N/A
- APYX N/A
- Revenue
- LUCD $4,360,000.00
- APYX $46,512,000.00
- Revenue This Year
- LUCD $22.80
- APYX $6.03
- Revenue Next Year
- LUCD $221.19
- APYX $4.96
- P/E Ratio
- LUCD N/A
- APYX N/A
- Revenue Growth
- LUCD 14.74
- APYX N/A
- 52 Week Low
- LUCD $0.73
- APYX $0.76
- 52 Week High
- LUCD $1.80
- APYX $2.73
- Technical
- Relative Strength Index (RSI)
- LUCD 50.26
- APYX 54.05
- Support Level
- LUCD N/A
- APYX $1.96
- Resistance Level
- LUCD $1.09
- APYX $2.11
- Average True Range (ATR)
- LUCD 0.09
- APYX 0.10
- MACD
- LUCD -0.06
- APYX -0.10
- Stochastic Oscillator
- LUCD 69.53
- APYX 100.00
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.